Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis

Figure 1

Total ion chromatogram (TIC) of plasma samples from pancreatic cancer (PC), diabetics (DM), and healthy controls (normal), indicating the PC- and DM-caused variation in the content of small molecule metabolites.